| 000 | 01496 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513064636.0 | ||
| 264 | 0 | _c19940701 | |
| 008 | 199407s 0 0 eng d | ||
| 022 | _a0039-2499 | ||
| 024 | 7 |
_a10.1161/01.str.25.6.1149 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOster, G | |
| 245 | 0 | 0 |
_aCost-effectiveness of ticlopidine in preventing stroke in high-risk patients. _h[electronic resource] |
| 260 |
_bStroke _cJun 1994 |
||
| 300 |
_a1149-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAspirin _xadverse effects |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xeconomics |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDecision Support Techniques |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGastrointestinal Hemorrhage _xetiology |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xcomplications |
| 650 | 0 | 4 | _aLife Expectancy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeutropenia _xetiology |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTiclopidine _xadverse effects |
| 700 | 1 | _aHuse, D M | |
| 700 | 1 | _aLacey, M J | |
| 700 | 1 | _aEpstein, A M | |
| 773 | 0 |
_tStroke _gvol. 25 _gno. 6 _gp. 1149-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.str.25.6.1149 _zAvailable from publisher's website |
| 999 |
_c8202279 _d8202279 |
||